E C Strain

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. pmc Induction of opioid-dependent individuals onto buprenorphine and buprenorphine/naloxone soluble-films
    E C Strain
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
    Clin Pharmacol Ther 89:443-9. 2011
  2. doi request reprint Drug use and sport--a commentary on: Injury, pain and prescription opioid use among former National Football League football players by Cottler et al
    Eric C Strain
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA
    Drug Alcohol Depend 116:8-10. 2011
  3. ncbi request reprint Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers
    E C Strain
    Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA
    Psychopharmacology (Berl) 148:374-83. 2000
  4. ncbi request reprint Effects of buprenorphine/naloxone in opioid-dependent humans
    K B Stoller
    Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD 21224, USA
    Psychopharmacology (Berl) 154:230-42. 2001
  5. ncbi request reprint Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humans
    S L Walsh
    Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA
    J Pharmacol Exp Ther 299:147-58. 2001
  6. ncbi request reprint Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial
    E C Strain
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA
    JAMA 281:1000-5. 1999
  7. ncbi request reprint Gradual dose taper following chronic buprenorphine
    A B Becker
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Am J Addict 10:111-21. 2001
  8. ncbi request reprint Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans
    S L Walsh
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA
    Psychopharmacology (Berl) 157:151-62. 2001
  9. pmc Discriminative stimulus effects of tramadol in humans
    Angela N Duke
    Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA
    J Pharmacol Exp Ther 338:255-62. 2011

Collaborators

Detail Information

Publications9

  1. pmc Induction of opioid-dependent individuals onto buprenorphine and buprenorphine/naloxone soluble-films
    E C Strain
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
    Clin Pharmacol Ther 89:443-9. 2011
    ..There was a significant decrease in COWS scores but no significant differences between the groups. The results support the use of B and B/N soluble films as safe and effective delivery methods for opioid induction...
  2. doi request reprint Drug use and sport--a commentary on: Injury, pain and prescription opioid use among former National Football League football players by Cottler et al
    Eric C Strain
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA
    Drug Alcohol Depend 116:8-10. 2011
    ....
  3. ncbi request reprint Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers
    E C Strain
    Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA
    Psychopharmacology (Berl) 148:374-83. 2000
    ..Non-parenteral abuse of opioids such as buprenorphine may be more likely in people who have less severe substance abuse disorders (e.g., are not physically dependent upon opioids)...
  4. ncbi request reprint Effects of buprenorphine/naloxone in opioid-dependent humans
    K B Stoller
    Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD 21224, USA
    Psychopharmacology (Berl) 154:230-42. 2001
    ..Low doses of injected buprenorphine/naloxone have been tested in opioid-dependent subjects, but higher doses (more than 2 mg of either medication) and direct comparisons to SL buprenorphine/naloxone have not been examined...
  5. ncbi request reprint Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humans
    S L Walsh
    Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA
    J Pharmacol Exp Ther 299:147-58. 2001
    ..These data suggest that these kappa-agonists may be safely administered in the presence of cocaine but do not produce significant attenuation of cocaine's direct effects or self-administration under these acute dosing conditions...
  6. ncbi request reprint Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial
    E C Strain
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA
    JAMA 281:1000-5. 1999
    ..However, despite recommendations regarding effective dosing of methadone, controlled clinical trials of higher-dose methadone have not been conducted...
  7. ncbi request reprint Gradual dose taper following chronic buprenorphine
    A B Becker
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Am J Addict 10:111-21. 2001
    ..Relapse may have been triggered by a desire to re-experience the drug's positive subjective effects, craving, or low motivation to remain drug-free. A longer taper combined with an expanded range of treatments may improve prognosis...
  8. ncbi request reprint Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans
    S L Walsh
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA
    Psychopharmacology (Berl) 157:151-62. 2001
    ....
  9. pmc Discriminative stimulus effects of tramadol in humans
    Angela N Duke
    Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA
    J Pharmacol Exp Ther 338:255-62. 2011
    ....